COLLEGIUM PHARMACEUTICAL, INC — All Filings
822 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
305B2
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001097 | Mar 26, 2026 | — |
| 4 | — | 0002061438-26-000006 | Mar 20, 2026 | Mar 18, 2026 |
| 8-K | FORM 8-K | 0001104659-26-032166 | Mar 19, 2026 | — |
| 144 | — | 0001959173-26-002479 | Mar 18, 2026 | — |
| 4 | — | 0002061438-26-000004 | Mar 11, 2026 | Mar 9, 2026 |
| 144 | — | 0001959173-26-002054 | Mar 9, 2026 | — |
| 4 | — | 0001746251-26-000004 | Mar 5, 2026 | Mar 3, 2026 |
| 144 | — | 0001959173-26-001837 | Mar 3, 2026 | — |
| 10-K | 10-K | 0001628280-26-011992 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-011990 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015179 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001580642-26-001061 | Feb 13, 2026 | — |
| 4 | — | 0002061438-26-000002 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | — | 0001699488-26-000002 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | — | 0001748462-26-000002 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | — | 0001862082-26-000002 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | — | 0001746251-26-000002 | Feb 12, 2026 | Feb 10, 2026 |
| 8-K | FORM 8-K | 0001104659-26-001953 | Jan 8, 2026 | — |
| 8-K | FORM 8-K | 0001104659-25-125026 | Dec 30, 2025 | Dec 23, 2025 |
| 144 | — | 0001104659-25-122027 | Dec 17, 2025 | — |
| 4 | — | 0001746251-25-000004 | Dec 10, 2025 | Dec 8, 2025 |
| 4 | — | 0001825625-25-000004 | Dec 9, 2025 | Dec 5, 2025 |
| 144 | — | 0001959173-25-007573 | Dec 8, 2025 | — |
| 4 | — | 0001699488-25-000004 | Nov 14, 2025 | Nov 12, 2025 |
| 4 | — | 0001560152-25-000004 | Nov 14, 2025 | Nov 12, 2025 |
| SCHEDULE 13G | — | 0001037389-25-000067 | Nov 13, 2025 | — |
| 144 | — | 0001959173-25-006960 | Nov 12, 2025 | — |
| 4 | — | 0001862082-25-000004 | Nov 7, 2025 | Nov 6, 2025 |
| 144 | — | 0001959173-25-006782 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001104659-25-107391 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001104659-25-107389 | Nov 6, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-015277 | Sep 3, 2025 | Aug 29, 2025 |
| 144 | — | 0002007317-25-000999 | Aug 29, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-014766 | Aug 20, 2025 | Aug 18, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-014694 | Aug 19, 2025 | Aug 15, 2025 |
| 144 | — | 0001959173-25-005316 | Aug 18, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-014526 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | — | 0000902664-25-003729 | Aug 15, 2025 | Aug 13, 2025 |
| 3 | — | 0000902664-25-003728 | Aug 15, 2025 | Aug 7, 2025 |
| 144 | — | 0001959173-25-005231 | Aug 15, 2025 | — |
| 144 | — | 0001959173-25-005172 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001037389-25-000044 | Aug 13, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-014202 | Aug 12, 2025 | Aug 8, 2025 |
| SCHEDULE 13G/A | — | 0001085146-25-004810 | Aug 11, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-010649 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001558370-25-010647 | Aug 7, 2025 | — |
| 144 | — | 0001959173-25-004515 | Jul 9, 2025 | — |
| 144 | — | 0001959173-25-004501 | Jul 8, 2025 | — |
| 144 | — | 0001959173-25-004478 | Jul 7, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-065981 | Jul 7, 2025 | Jul 1, 2025 |